Elsevier

Neuropharmacology

Volume 27, Issue 2, February 1988, Pages 111-122
Neuropharmacology

Evidence for histaminergic arousal mechanisms in the hypothalamus of cat

https://doi.org/10.1016/0028-3908(88)90159-1Get rights and content

Abstract

Polygraphic 23-hr recordings were carried out in 25 adult cats in order to examine the effects of both systemic and local injections of various histaminergic and antihistaminergic drugs on sleep-waking cycles. α-Fluroromethylhistidine (α-FMH), a specific inhibitor of histidine decarboxylase, when injected intraperitoneally at a dose of 20 mg/kg, induced a significant increase in deep slow wave sleep (S2) and a decrease in wakefulness (W), without modifying light slow wave sleep (S1) and paradoxical sleep (PS). Intraperitoneal injections of mepyramine (1 mg and 5 mg/kg), a well-known histamine H1-receptor antagonist, increased deep slow wave sleep and decreased wakefulness, as well as paradoxical sleep. Bilateral injections of α-FMH (50 μg/l μl) into the ventrolateral posterior hypothalamus, where histamine immunoreactive neurones have been recently identified, resulted in a significant decrease in wakefulness and increase in deep slow wave sleep. Similarly, injections of mepyramine (120 μg/1 μl) in the same structures caused a significant decrease in wakefulness and an increase in deep slow wave and paradoxical sleep as well. In contrast, local injections of SKF-91488 (50 μg/l μl), a specific inhibitor of histamine-N-methyltransferase, led to a significant increase in wakefulness and decrease in both slow wave sleep (SWS) and paradoxical sleep. Injections of histamine, at doses of 5, 30 and 60 μg/1 μl, also increased wakefulness and decreased slow wave sleep dose dependently, while these effects were completely blocked by pretreatment with mepyramine. The results suggest that histaminergic systems in the hypothalamus play an important role in arousal mechanisms and their actions are mediated through H1-receptors.

References (57)

  • F. Roberts et al.

    Histamine and hypothalamus

    Neuroscience

    (1983)
  • B.S.R. Sastry et al.

    Depression of rat cerebral cortical neurons by H1 and H2 histamine receptor agonists

    Eur. J. Pharmac.

    (1976)
  • T.A. Slotkin et al.

    effects of α-fluoromethylhistidine, an irreversible inhibitor of histidine decarboxylase, on development of brain histamine and catecholamine systems in the neonatal rat

    Life Sci.

    (1983)
  • H. Takagi et al.

    Histaminergic axons in the neostriatum and cerebral cortex of the rat: a correlated light and electron microscopic immunocytochemical study using histidine decarboxylase as a marker

    Brain Res.

    (1986)
  • T. Watanabe et al.

    Distribution of the histaminergic system in the central nervous system of rats: a fluorescent immunohistochemical analysis with histidine decarboxylase as a marker

    Brain Res.

    (1984)
  • A. Wauquier et al.

    A comparison between astemizole and other antihistamines on sleep-wakefulness cycle in dogs

    Neuropharmacology

    (1981)
  • G. Aston-Jones et al.

    Activity of norepinephrine-containing locus coeruleus neurons in rats anticipates fluctuations in the sleep-waking cycle

    J. Neurosci

    (1981)
  • J.L. Bassono et al.

    Effects of two antihistaminic compounds (maquitazine, dexchlorpheniramine) on sleep, sleep distorsion by antihistaminics

    Waking Sleeping

    (1979)
  • M.A. Beaven et al.

    Inhibition of histamine methylation in vivo by the dimaprit analog compound SKF91488

    Agents Actions

    (1979)
  • M. Bouchlier et al.

    Effect of prolonged inhibition of histidine decarboxylase on tissue histamine concentration

    Experimentia

    (1983)
  • P.B. Bradley

    Synaptic transmission in the central nervous system and its relevance for drug action

    Int. Rev. Neurobiol.

    (1968)
  • W.W. Douglas

    Histamine and 5-hydroxytryptamine (Serotonin) and their antagonists

  • C. Economo

    Die Pathologie des Schlafes

  • M. Garbarg et al.

    Histaminergic pathway in rat brain evidenced by lesions of the M.F.B

    Science

    (1974)
  • M. Garbarg et al.

    Inhibition of histamine synthesis in brain by α-fluoromethylhistidine, a new irreversible inhibitor: in vitro and in vivo studies

    J. Neurochem.

    (1980)
  • P.M. Gross

    Cerebral histamine: indication for neuronal and vascular regulation

    J. Cereb. Blood Flow Metab.

    (1982)
  • H.L. Haas

    Histamine

  • P.W. Kalivas

    Histamine-induced arousal in the conscious and pentobarbital pretreated rat

    J. Pharmac. Exp. Ther.

    (1982)
  • Cited by (0)

    View full text